Quantcast
Last updated on April 23, 2014 at 15:23 EDT

Latest Proton therapy Stories

2010-03-24 16:29:00

PALO ALTO, Calif., March 24 /PRNewswire-FirstCall/ -- Varian Medical Systems (NYSE: VAR) invites investors and members of the financial community for a special presentation where members of senior management will unveil new technologies and approaches for radiotherapy and radiosurgery. The breakfast meeting will take place from 7:30 a.m. to 9:00 a.m. on Wednesday, April 14, 2010, in the IAC Building, 555 W. 18th St., New York. Seating is limited and will be assigned via reservations on a...

2010-03-17 07:00:00

BEIJING, March 17 /PRNewswire-FirstCall/ -- Varian Medical Systems, Inc. (NYSE: VAR), the world's leading manufacturer of medical technology for treating cancer with radiotherapy and radiosurgery, will showcase its technology at two medical events in Asia during the month of March: 13th Asian Oceanian Congress of Radiology in Taipei (AOCR), March 20-23 The 22nd International Medical Instruments & Equipment Exhibition in Beijing (ChinaMed), March 26-28 AOCR At AOCR, for the first time...

2010-03-16 13:31:43

Study participants appear less distressed than expected by chronic symptoms Boosting the radiation dose given to prostate cancer patients to a level that cut tumor recurrence in half did not increase the severity of side effects reported by patients up to a decade later. The study led by Massachusetts General Hospital (MGH) Cancer Center researchers also found that patients characterized the impact of continuing side effects on their quality of life as considerably less bothersome than would...

2010-03-11 07:00:00

MUNICH, March 11 /PRNewswire-FirstCall/ -- Clinicians at the Rinecker Proton Therapy Center (RPTC) in Munich have treated their 100th patient using advanced proton therapy systems supplied by Varian Medical Systems (NYSE: VAR). The landmark treatment comes just three months after a second treatment gantry was commissioned at the center, which offers advanced pencil-beam proton scanning to cancer patients. These patients, requiring treatment for a wide range of cancers, have come from...

2010-03-10 07:00:00

MAIDSTONE, England, March 10 /PRNewswire-FirstCall/ -- Cancer patients in Kent will gain access to advanced radiotherapy treatments with the decision by the Kent Oncology Centre to acquire two fully-equipped treatment machines from Varian Medical Systems (NYSE: VAR). The machines, due to be delivered to oncology departments in Maidstone and Canterbury in the spring, will mean these departments are among the first in the country to offer fast and efficient RapidArc®...

2010-03-08 13:28:35

Prostate-specific dietary supplements should not be taken during radiation therapy treatments because they have been shown to increase the radiosensitivity of normal prostate cell lines, leading to normal tissue complications, according to a study in the March issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO). Many prostate cancer patients choose to take nutritional supplements to improve or...

2010-03-03 07:44:00

PALO ALTO, Calif., March 3 /PRNewswire/ -- Researchers in the US and Denmark have made a breakthrough in image-guided targeting of prostate tumors during arc radiotherapy treatments. In research partially supported by Varian Medical Systems (NYSE: VAR), physicists at Stanford University (California, USA) and Aarhus University Hospital (Aarhus, Denmark) have devised a method for 'real-time' tracking of the prostate motion using Varian's On-Board Imager® that shows promise...

2010-02-25 14:00:00

Proton beam radiation therapy shows encouraging results for patients with locally advanced sinonasal malignancies, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and SNM. Sinonasal cancers are very rare but aggressive types of cancer. Patients usually present with advanced stage with tumors involving normal structures in the skull base such as eyes, optic nerves, brain. Between 1991 and 2003, 99 patients with newly...

2010-02-24 07:00:00

WEST CHICAGO, Ill., Feb. 24 /PRNewswire/ -- Scientists and researchers from the Northern Illinois Proton Treatment and Research Center (NIPTRC) and Northern Illinois University along with their partners are developing a new imaging process using a proton beam that they believe will be a major medical breakthrough in the delivery of proton beam therapy for cancer patients. Research Director and Chief Physicist George Coutrakon, Ph.D. says it demonstrates that NIPTRC and NIU are already...

2010-02-22 07:00:00

PALO ALTO, Calif., Feb. 22 /PRNewswire-FirstCall/ -- Varian Medical Systems (NYSE: VAR) will be displaying its extensive range of radiotherapy and brachytherapy technology advancements at the annual American College of Radiation Oncology (ACRO) conference in Lake Buena Vista, Florida, later this week. Varian can be found on Booths 34 and 35. In advance of the show, Varian is hosting an educational symposium on February 24th focusing on the practical implementation of high dose rate...